Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis ; volume:10 ; number:3 ; day:28 ; month:11 ; year:2012 ; pages:1 ; date:11.2012
Journal of translational medicine ; 10, Heft 3 (28.11.2012), 1, 11.2012
- Urheber
-
Ćalasan, Maja Bulatović
- Beteiligte Personen und Organisationen
-
Vastert, Sebastiaan
Verweij, Frederik
Wulffraat, Nico
van Wijk, Femke
Prakken, Berent
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-10-S3-P40
- URN
-
urn:nbn:de:1111-2016041443796
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ćalasan, Maja Bulatović
- Vastert, Sebastiaan
- Verweij, Frederik
- Wulffraat, Nico
- van Wijk, Femke
- Prakken, Berent
- SpringerLink (Online service)
Ähnliche Objekte (12)
Predictors of response to methotrexate in juvenile idiopathic arthritis
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Predictors of response to methotrexate in juvenile idiopathic arthritis
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Predictors of response to methotrexate in juvenile idiopathic arthritis
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance